Characteristics | n (%) |
---|---|
Total | 90,740 |
Age | 63 (53–70) |
Sex | |
 Male | 41,162 (45.4%) |
 Female | 49,578 (54.6%) |
Weight (kg) | 73.5 (59.8–84.0) |
Cardiac Adverse Events | 8300 (9.1%) |
 Myocarditis | 345 (0.4%) |
 Pericarditis | 143 (0.2%) |
 Heart Failure | 1706 (1.9%) |
 Myocardial Infarction | 1594 (1.8%) |
 Arrhythmias | 3858 (4.3%) |
 Coronary Artery Disease | 654 (0.7%) |
Anti-inflammatory medication use | 18,797 (20.7%) |
Cardioprotective medication use | 23,372 (25.8%) |
Treatment groups | |
 anti-PD-(L)1 | 18,536 (20.4%) |
 anti-CTLA4 | 1855 (2%) |
 combination immunotherapy | 4442 (4.9%) |
 Chemotherapy | 65,907 (72.6%) |